Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice

Chemical Research in Toxicology
K HePaul F Hollenberg

Abstract

Grapefruit juice has been found to significantly increase oral bioavailability of several drugs metabolized by cytochrome P450 3A4 (P450 3A4) through inhibiting the enzymatic activity and decreasing the content of intestinal P450 3A4. HPLC/MS/MS and HPLC/UV analyses of ethyl acetate extracts from grapefruit juice revealed the presence of several furanocoumarins of which bergamottin (BG) is the major one. BG was shown to inactivate P450 3A4 in a reconstituted system consisting of purified P450 3A4, NADPH-cytochrome P450 reductase, cytochrome b5, and phospholipids. Inactivation was time- and concentration-dependent and required metabolism of BG. The loss of catalytic activity exhibited pseudo-first-order kinetics. The values of kinactivation and KI calculated from the inactivation studies were 0.3 min-1 and 7.7 microM, respectively. While approximately 70% of the erythromycin N-demethylation activity was lost during incubation with BG in the reconstituted system, P450 3A4 retained more than 90% of the heme as determined either by UV-visible spectroscopy or by HPLC. However, approximately 50% of the apoP450 in the BG-inactivated P450 3A4 incubation mixture could not be recovered from a reverse-phase HPLC column when compared with ...Continue Reading

References

May 15, 1987·Archives of Biochemistry and Biophysics·A J SonderfanA Parkinson
Oct 1, 1987·The Journal of Clinical Investigation·P B WatkinsP S Guzelian
Jan 1, 1984·Annual Review of Biochemistry·C T Walsh
Jan 1, 1996·Contraception·A WeberA Balogh
Jan 1, 1996·European Journal of Clinical Pharmacology·J VanakoskiT Seppälä

❮ Previous
Next ❯

Citations

May 19, 2009·Archives of Toxicology·Arthur I CederbaumDefeng Wu
Dec 6, 2011·Archives of Pharmacal Research·Young Hee ChoiYoon Gyoon Kim
Dec 16, 2003·Life Sciences·Shufeng ZhouEdmund Jon Deoon Lee
Jan 23, 2002·Chemico-biological Interactions·Petr HodekMarie Stiborová
Apr 27, 1999·Atherosclerosis·M AviramP F Hollenberg
Sep 29, 2001·Advanced Drug Delivery Reviews·D WagnerP Langguth
Jun 6, 2000·Advanced Drug Delivery Reviews·X Li, W K Chan
Aug 31, 2001·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·I StupansP J Hayball
Jan 16, 2003·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·M GiorgiG Soldani
Mar 29, 2001·Journal of Pharmacological and Toxicological Methods·S EkinsS A Wrighton
Oct 16, 2012·Chemical Research in Toxicology·Lisa A Peterson
Apr 12, 2000·British Journal of Clinical Pharmacology·C C LibersaM A Lhermitte
May 13, 2009·American Journal of Therapeutics·Joseph Prandota
Feb 22, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Hsia-Lien LinPaul F Hollenberg
Mar 24, 2004·Inflammopharmacology·Costas Ioannides
Jul 17, 2004·Biological & Pharmaceutical Bulletin·Tetsuya SaitaMasato Mori
Jun 7, 2006·Biological & Pharmaceutical Bulletin·Yoshihiro Uesawa, Kiminori Mohri
Nov 2, 2006·Biological & Pharmaceutical Bulletin·Yoshihiro Uesawa, Kiminori Mohri
May 3, 2008·Biological & Pharmaceutical Bulletin·Tadashi FujitaMasahiro Iwaki
Nov 8, 2005·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Yoshihiro Uesawa, Kiminori Mohri
Nov 8, 2005·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Yoshihiro Uesawa, Kiminori Mohri
Jan 8, 2008·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Yoshihiro Uesawa, Kiminori Mohri
Mar 25, 2008·Therapeutics and Clinical Risk Management·Shufeng ZhouMin Huang
Mar 15, 2005·Clinical Pharmacokinetics·Shufeng ZhouHoward L McLeod
Dec 15, 2010·Drugs·Kay SedenDavid Back
May 3, 2011·American Journal of Veterinary Research·Noel E RadwanskiMichael H Court
Sep 27, 2008·Journal of Clinical Biochemistry and Nutrition·Hirotaka SekiguchiAkira Murakami
Nov 26, 2013·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Robert Roskoski
Apr 10, 2004·Drug Metabolism Reviews·Shufeng ZhouBalram Chowbay
May 26, 2011·Expert Opinion on Drug Metabolism & Toxicology·Zhong-Ze FangLing Yang
Jul 26, 2006·Expert Opinion on Drug Metabolism & Toxicology·Jose M Jimenez-Lopez, Arthur I Cederbaum
Feb 3, 2007·Expert Opinion on Drug Metabolism & Toxicology·Maria Almira Correia, Mingxiang Liao
Feb 3, 2007·Expert Opinion on Drug Metabolism & Toxicology·Mary F Paine, Nicholas H Oberlies
Apr 25, 2008·Expert Opinion on Drug Metabolism & Toxicology·Dora Farkas, David J Greenblatt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.